In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...
Novartis will construct an active pharmaceutical ingredient (API) facility in Morrisville, North Carolina, the company said ...
Lupin is having continued difficulty solving problems at its factory in Tarapur, India, and has received another warning letter from the FDA, the generics producer revealed in a regulatory filing.
Novartis has finalized its $23 billion U.S. manufacturing and R&D expansion with plans for a new active pharmaceutical ingredient facility in Morrisville, North Carolina. The 56,200-square-foot site ...
The new plant will give Novartis end-to-end capabilities centered on North Carolina, where it plans to have five facilities ...
The US Food and Drug Administration (FDA) on Tuesday released a warning letter sent 10 April to Teva for deficiencies related to an active pharmaceutical ingredient (API) manufacturing site in ...
Emzor Pharmaceutical Industries Limited, a leading pharmaceutical company in Nigeria, has announced a ground-breaking $230 million investment in a new Active Pharmaceutical Ingredients (API) ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Company invests $800,000 in new equipment. © 2026 American ...
JGC Holdings, an engineering company headquartered in Yokohama, Japan, has been awarded a contract by Chugai Pharmaceutical to build an active pharmaceutical ingredient (API) manufacturing plant for ...
Emzor Pharmaceutical Industries Limited has stated that its $23m Active Pharmaceutical Ingredient production plant would help to reduce Nigeria’s drug import by 2026. In a statement issued by the Head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results